Superstring Capital Management

Superstring Capital Management as of March 31, 2026

Portfolio Holdings for Superstring Capital Management

Superstring Capital Management holds 35 positions in its portfolio as reported in the March 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Summit Therapeutics (SMMT) 12.1 $17M 893k 18.96
Immunovant (IMVT) 6.3 $8.9M 358k 24.84
Cogent Biosciences (COGT) 6.2 $8.7M 225k 38.49
Savara (SVRA) 6.2 $8.7M 1.6M 5.46
Urogen Pharma (URGN) 5.0 $7.0M 387k 17.98
Definium Therapeutics Com Shs (DFTX) 4.7 $6.6M 352k 18.90
Vir Biotechnology (VIR) 4.7 $6.5M 731k 8.96
Vaxcyte (PCVX) 4.6 $6.4M 111k 58.11
Celldex Therapeutics Com New (CLDX) 4.1 $5.7M 180k 31.72
Sionna Therapeutics (SION) 4.0 $5.7M 141k 40.09
Genmab A/s Sponsored Ads (GMAB) 3.8 $5.3M 197k 26.83
Zai Lab Adr (ZLAB) 3.7 $5.2M 276k 18.81
Vertex Pharmaceuticals Incorporated (VRTX) 3.5 $4.9M 11k 446.54
Iqvia Holdings (IQV) 3.1 $4.4M 26k 170.54
Maplight Therapeutics (MPLT) 2.8 $3.9M 192k 20.33
Arvinas Ord (ARVN) 2.4 $3.3M 313k 10.60
Oruka Therapeutics (ORKA) 2.2 $3.1M 64k 49.05
United Therapeutics Corporation (UTHR) 2.2 $3.1M 5.2k 592.98
Travere Therapeutics (TVTX) 2.2 $3.1M 103k 29.71
Trevi Therapeutics (TRVI) 2.1 $3.0M 252k 11.93
Adlai Nortye Sponsored Ads (ANL) 2.1 $2.9M 415k 6.92
Cabaletta Bio (CABA) 2.0 $2.9M 1.1M 2.69
Pfizer (PFE) 1.5 $2.1M 74k 28.08
Axsome Therapeutics (AXSM) 1.4 $1.9M 11k 169.02
Oric Pharmaceuticals (ORIC) 1.0 $1.5M 115k 12.67
Aclaris Therapeutics (ACRS) 1.0 $1.4M 367k 3.75
Eliem Therapeutics (CLYM) 1.0 $1.4M 199k 6.85
Taysha Gene Therapies Com Shs (TSHA) 0.8 $1.2M 258k 4.47
Bright Minds Biosciences Com New (DRUG) 0.7 $971k 13k 72.97
Tonix Pharmaceuticals Hldg C Com New (TNXP) 0.6 $874k 64k 13.75
Cullinan Oncology (CGEM) 0.6 $845k 60k 14.21
Protara Therapeutics Com Stk (TARA) 0.5 $633k 122k 5.21
Palatin Technologies Com New (PTN) 0.4 $627k 36k 17.42
Biomea Fusion (BMEA) 0.3 $383k 250k 1.53
Century Therapeutics (IPSC) 0.2 $270k 119k 2.26